Aigen Investment Management, LP
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1741224
NEW YORK, NY
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$246,323
-$14,007 QoQ
Shares Held
3,022
-60.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#363
of 497 holders
Holding Since
Mar 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aigen Investment Management, LP holds $12,762,383 across 22 Biotechnology names. ARWR ranks #9 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,452 | $3,701,631 | |
| 2 | INCY |
Incyte Corp
|
23,563 | $2,671,101 | |
| 3 | INSM |
INSMED Inc
|
16,847 | $1,796,227 | |
| 4 | ASND |
Ascendis Pharma A/S
|
4,073 | $1,086,350 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
2,390 | $585,000 | |
| 6 | SMMT |
Summit Therapeutics Inc.
|
24,477 | $356,629 | |
| 7 | JANX |
Janux Therapeutics, Inc.
|
22,841 | $350,837 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
5,218 | $314,958 |
All Filings in ARWR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $246,323 | 3,022 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $260,330 | 7,548 | Shares | Sole | 2025-11-14 | |
| 2023-09-30 | $944,211 | 35,140 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $357,313 | 10,020 | Shares | Sole | 2023-08-14 | |
| 2021-06-30 | $831,678 | 10,042 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $226,780 | 3,420 | Shares | Sole | 2021-05-11 | |
| No filing history on record for this holder in this stock. | ||||||